Green Thumb Industries (OTCMKTS:GTBIF) Issues Earnings Results

Green Thumb Industries (OTCMKTS:GTBIF) issued its quarterly earnings results on Wednesday. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02), Zacks reports. Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%.

Green Thumb Industries Price Performance

Green Thumb Industries stock traded up $0.24 during midday trading on Wednesday, reaching $6.98. The stock had a trading volume of 123,561 shares, compared to its average volume of 471,339. The firm’s fifty day simple moving average is $7.39 and its two-hundred day simple moving average is $9.04. Green Thumb Industries has a twelve month low of $6.60 and a twelve month high of $16.33. The firm has a market cap of $1.48 billion, a price-to-earnings ratio of 29.08 and a beta of 1.32.

Analyst Upgrades and Downgrades

Separately, Roth Capital raised Green Thumb Industries to a “strong-buy” rating in a report on Sunday, November 10th. Two research analysts have rated the stock with a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, Green Thumb Industries currently has an average rating of “Strong Buy” and an average price target of $16.50.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.